Pacira Pharmaceuticals (PCRX) PT Lowered at Wedbush; 'Outperform' Maintained
Tweet Send to a Friend
Wedbush analyst Liana Moussatos lowered her price target on Pacira Pharmaceuticals (NASDAQ: PCRX) to $116.00 (from $127.00) noting the Symphony ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
